Correspondence to letter to the editor on “DNMT1 facilitates the progression of metabolic dysfunction-associated steatotic liver disease by impeding transcription mediated by HNF4α and PPARα”
Clinical and Molecular Hepatology · 30.10.2026
DOI: 10.3350/cmh.2026.0292 ↗Kurz gefasst
Kommentar in der Zeitschrift Clinical and Molecular Hepatology, online erschienen am 30.10.2026. Verfasst von Hyun Ahm Sohn und 3 weiteren Autor:innen. Beteiligte Einrichtung: Aging Convergence Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Daejeon, Korea. Die Arbeit nennt 15 Literaturangaben.
Abstract (Originalsprache)
Their editorial provides valuable mechanistic and translational perspectives on our identification of the DNA methyltransferase 1 (DNMT1)-hepatocyte nuclear factor 4 alpha (HNF4α)-phosphoenolpyruvate carboxykinase 1 (PCK1) axis in metabolic dysfunction-associated steatotic liver disease (MASLD).Here, we address the three main issues raised in their commentary.First, the editorial correctly notes that our analysis of promoter-proximal DNA methylation does not fully capture the contribution of higher-order chromatin architecture, includ-ing CCCTC-binding factor (CTCF) dependent topologically associating domain (TAD) organization or enhancer-promoter communication.We agree that while our data show that 5-aza-4′ -thio-2′ -deoxycytidine (Aza-TdC) treatment and CRISPR-based epigenome editing restore HNF4α occupancy and PCK1 transcription, these results do not demonstrate the reconstitution of TAD integrity.DNA hypermethylation at CTCF sites or other architectural elements may disrupt insulated chromatin neighborhoods and distal regulatory interactions-alterations not resolvable by linear methylation or ChIP-based profiling alone.3 Whether Aza-TdC restores enhancer-promoter contacts at the PCK1 locus or re-establishes global chromatin topology remains unknown.Future studies combining genome-wide 3D chro-
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Aging Convergence Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Daejeon, Korea.
- Department of Functional Genomics, KRIBB School of Bioscience, Korea University of Science and Technology (UST), Daejeon, Korea.
- Department of Internal Medicine, Seoul National University College of Medicine, Seoul Metropolitan Government Boramae Medical Center, Seoul, Korea. drwon1@snu.ac.kr.
- Aging Convergence Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Daejeon, Korea. mirang@kribb.re.kr.
- Department of Functional Genomics, KRIBB School of Bioscience, Korea University of Science and Technology (UST), Daejeon, Korea. mirang@kribb.re.kr.
Zitieren
APA
Sohn, H. A., Go, H., Kim, W., & Kim, M. (2026). Correspondence to letter to the editor on “DNMT1 facilitates the progression of metabolic dysfunction-associated steatotic liver disease by impeding transcription mediated by HNF4α and PPARα”. Clinical and Molecular Hepatology. https://doi.org/10.3350/cmh.2026.0292
Vancouver
Sohn HA, Go H, Kim W, Kim M. Correspondence to letter to the editor on “DNMT1 facilitates the progression of metabolic dysfunction-associated steatotic liver disease by impeding transcription mediated by HNF4α and PPARα”. Clinical and Molecular Hepatology. 2026. doi:10.3350/cmh.2026.0292
BibTeX
@article{Sohn2026,
author = {Sohn, Hyun Ahm and Go, Hanyong and Kim, Won and Kim, Mirang},
title = {Correspondence to letter to the editor on “DNMT1 facilitates the progression of metabolic dysfunction-associated steatotic liver disease by impeding transcription mediated by HNF4α and PPARα”},
journal = {Clinical and Molecular Hepatology},
year = {2026},
doi = {10.3350/cmh.2026.0292}
}
EUVIMED